JBIO
Jade Biosciences, Inc.Company with tickers: JBIO
CIK
1798749
CUSIP
008064206
Shares Outstanding
49,359,875
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-12 | Dahms Bradford D. | Chief Financial Officer | Award | 226,875 |
| 2026-02-12 | Dahms Bradford D. | Chief Financial Officer | Award | 37,813 |
| 2026-02-12 | Balta Elizabeth | See Remarks | Award | 28,125 |
| 2026-02-12 | Balta Elizabeth | See Remarks | Award | 168,750 |
| 2026-02-12 | King Andrew James | See Remarks | Award | 247,500 |
| 2026-02-12 | King Andrew James | See Remarks | Award | 41,250 |
| 2026-02-12 | Frohlich Tom | Director, Chief Executive Officer | Award | 472,500 |
| 2026-02-12 | Frohlich Tom | Director, Chief Executive Officer | Award | 78,750 |
| 2025-10-06 | Fairmount Funds Management LLC | Director | Other | 2,655,817 |
| 2025-10-06 | Fairmount Funds Management LLC | Director | Award | 855,047 |
| 2025-10-06 | Fairmount Funds Management LLC | Director | Award | 1,333,126 |
| 2025-07-14 | Dahms Bradford D. | Chief Financial Officer | Other | 0 |
| 2025-07-14 | Dahms Bradford D. | Chief Financial Officer | Award | 526,000 |
| 2025-05-16 | Frohlich Tom | Director, Chief Executive Officer | Buy | 6,000 |
| 2025-04-29 | DOBMEIER ERIC | Director | Award | 23,017 |
| 2025-04-29 | CAIN CHRISTOPHER W. | Director | Award | 23,017 |
| 2025-04-29 | Lavelle Erin | COO & CFO | Award | 23,017 |
| 2025-04-29 | Klein Lawrence Otto | Director | Award | 23,017 |
| 2025-04-29 | Fairmount Funds Management LLC | Director | Award | 23,017 |
| 2025-04-28 | Balta Elizabeth | See Remarks | Other | 0 |
| 2025-04-28 | Balta Elizabeth | See Remarks | Other | 0 |
| 2025-04-28 | DOBMEIER ERIC | Director | Other | 0 |
| 2025-04-28 | DOBMEIER ERIC | Director | Other | 0 |
| 2025-04-28 | Lavelle Erin | COO & CFO | Other | 0 |
| 2025-04-28 | Lavelle Erin | COO & CFO | Other | 0 |
| 2025-04-28 | King Andrew James | See Remarks | Other | 0 |
| 2025-04-28 | King Andrew James | See Remarks | Other | 0 |
| 2025-04-28 | King Andrew James | See Remarks | Other | 344,863 |
| 2025-04-28 | King Andrew James | See Remarks | Other | 0 |
| 2025-04-28 | King Andrew James | See Remarks | Other | 0 |
| 2025-04-28 | Kocinsky Hetal | Chief Medical Officer | Other | 0 |
| 2025-04-28 | Kocinsky Hetal | Chief Medical Officer | Other | 0 |
| 2025-04-28 | CAIN CHRISTOPHER W. | Director | Other | 0 |
| 2025-04-28 | Klein Lawrence Otto | Director | Other | 86,215 |
| 2025-04-28 | Klein Lawrence Otto | Director | Other | 0 |
| 2025-04-28 | Frohlich Tom | Director, Chief Executive Officer | Other | 0 |
| 2025-04-28 | Frohlich Tom | Director, Chief Executive Officer | Other | 0 |
| 2025-04-28 | Frohlich Tom | Director, Chief Executive Officer | Other | 0 |
| 2025-04-28 | Quick Jonathan | See Remarks | Other | 0 |
| 2025-04-28 | Quick Jonathan | See Remarks | Other | 0 |
| 2025-04-28 | Fairmount Funds Management LLC | Director | Other | 564,551 |
| 2025-04-28 | Fairmount Funds Management LLC | Director | Other | 0 |
| 2025-04-28 | Fairmount Funds Management LLC | Director | Other | 2,655,817 |
| 2025-04-28 | Fairmount Funds Management LLC | Director | Other | 0 |
| 2025-04-28 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 28,206 |
| 2025-04-28 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 1,062,326 |
| 2025-04-28 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 8,890 |
| 2024-08-01 | Dake Benjamin T | SEE REMARKS | Convert | 1,507 |
| 2024-08-01 | Dake Benjamin T | SEE REMARKS | Convert | 1,507 |
| 2024-07-31 | Dake Benjamin T | SEE REMARKS | Convert | 906 |
| 2024-07-31 | Dake Benjamin T | SEE REMARKS | Convert | 10,548 |
| 2024-07-31 | Dake Benjamin T | SEE REMARKS | Convert | 11,454 |
| 2024-06-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 928,110 |
| 2024-06-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 311,170 |
| 2024-06-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 987,244 |
| 2024-06-14 | Eldridge George A | SEE REMARKS | Convert | 15,000 |
| 2024-06-14 | Eldridge George A | SEE REMARKS | Convert | 15,000 |
| 2024-06-14 | Eldridge George A | SEE REMARKS | Sell | 15,000 |
| 2024-06-14 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | Sell | 10,600 |
| 2024-06-14 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | Convert | 10,600 |
| 2024-06-14 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | Convert | 10,600 |
| 2024-06-13 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 6,000 |
| 2024-06-13 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | 6,000 |
| 2024-06-13 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 6,000 |
| 2024-06-05 | Santel Donald J | Director | Award | 12,500 |
| 2024-06-05 | Resnick Joshua | Director | Award | 12,500 |
| 2024-06-05 | Dable Habib J | Director | Award | 12,500 |
| 2024-06-05 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 12,500 |
| 2024-06-05 | Katabi Maha | Director | Award | 12,500 |
| 2024-06-05 | Iwicki Mark T | Director | Award | 12,500 |
| 2024-06-05 | GRAYZEL DAVID S. | Director | Award | 12,500 |
| 2024-06-05 | Dorval Allison | Director | Award | 12,500 |
| 2024-05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | 3,914 |
| 2024-05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 4,000 |
| 2024-05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | 86 |
| 2024-05-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 4,000 |
| 2024-05-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Convert | 10,000 |
| 2024-05-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Convert | 10,000 |
| 2024-05-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 8,707 |
| 2024-05-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 1,293 |
| 2024-05-02 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | Sell | 1,981 |
| 2024-05-01 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 9,035 |
| 2024-05-01 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 1,357 |
| 2024-05-01 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Convert | 10,000 |
| 2024-05-01 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 965 |
| 2024-05-01 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Convert | 10,000 |
| 2024-04-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 4,000 |
| 2024-04-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | 3,689 |
| 2024-04-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | 311 |
| 2024-04-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 3,497 |
| 2024-04-17 | Gillies Hunter | CHIEF MEDICAL OFFICER | Convert | 503 |
| 2024-04-17 | Dake Benjamin T | SEE REMARKS | Convert | 6,853 |
| 2024-04-17 | Dake Benjamin T | SEE REMARKS | Sell | 6,447 |
| 2024-04-17 | Dake Benjamin T | SEE REMARKS | Convert | 6,853 |
| 2024-04-17 | Dake Benjamin T | SEE REMARKS | Sell | 68 |
| 2024-04-17 | Dake Benjamin T | SEE REMARKS | Sell | 338 |
| 2024-04-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Convert | 10,000 |
| 2024-04-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 5,509 |
| 2024-04-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Sell | 4,491 |
| 2024-04-16 | NOYES TIMOTHY P | Director, CHIEF EXECUTIVE OFFICER | Convert | 10,000 |